Identification of pharmacogenetic markers in smoking cessation therapy (Q37127185)

18 August 2017

Identification of pharmacogenetic markers in smoking cessation therapy (English)

1 reference

18 August 2017

6

Caryn Lerman

1 reference

18 August 2017

Daniel F Heitjan

1

1 reference

18 August 2017

Mengye Guo

2

1 reference

18 August 2017

Riju Ray

3

1 reference

18 August 2017

E Paul Wileyto

4

1 reference

18 August 2017

Leonard H Epstein

5

1 reference

18 August 2017

1 September 2008

1 reference

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

18 August 2017

1 reference

18 August 2017

147B

1 reference

18 August 2017

6

1 reference

18 August 2017

712-719

1 reference

Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

Novel genes identified in a high-density genome wide association study for nicotine dependence

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

Pharmacogenomics and individualized drug therapy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

Exploratory Bayesian model selection for serial genetics data

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

Priorities and standards in pharmacogenetic research

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

A new mixture model approach to analyzing allelic-loss data using Bayes factors

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

Behavioral and biochemical investigations of bupropion metabolites

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

Genetic and functional analysis of single nucleotide polymorphisms in the beta2-neuronal nicotinic acetylcholine receptor gene (CHRNB2)

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

Bupropion is a nicotinic antagonist.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

The alpha 5 gene product assembles with multiple acetylcholine receptor subunits to form distinctive receptor subtypes in brain

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

Nicotinic receptor subtypes in rat hippocampal slices are differentially sensitive to desensitization and early in vivo functional up-regulation by nicotine and to block by bupropion

27 June 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.30669

Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.30669

Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.30669

Characterization of the genomic structure of the human neuronal nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster and identification of novel intragenic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.30669

Bayesian robust inference for differential gene expression in microarrays with multiple samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.30669

Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.30669

HIV-1 viral fitness estimation using exchangeable on subsets priors and prior model selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.30669

CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.30669

The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.30669

Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.30669

Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.30669

Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.30669

Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.30669

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.30669

Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

The dopamine D2 receptor C32806T polymorphism (DRD2 Taq1A RFLP) exhibits no association with smoking behaviour in a healthy UK population

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

Haplotypes of four novel single nucleotide polymorphisms in the nicotinic acetylcholine receptor beta2-subunit (CHRNB2) gene show no association with smoking initiation or nicotine dependence

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2655206

3 September 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.30669

A sharper Bonferroni procedure for multiple tests of significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.30669

Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18165968

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/AJMG.B.30669

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

18165968

1 reference